Technology
This biohacking company is using a crypto city to test controversial gene therapies
The advertisement—posted on Mirror, a Web3 publishing platform, in March last year—outlined an eye-catching if perhaps confusing proposal: “Access NFTs for a follistatin plasmid phase I clinical trial in Prospera ZEDE, Honduras.” The ad had been posted by a biotech startup called Minicircle, which was recruiting participants for a clinical trial of gene therapy…
Read More